SYNCOM FORMULATIONS Fact Sheet, SYNCOM FORMULATIONS Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SYNCOM FORMULATIONS Fact Sheet    (SFRM)


Watch: Predict Stock's Next Move Using Volumes


Here is the latest financial fact sheet of SYNCOM FORMULATIONS. For more details, see the SYNCOM FORMULATIONS quarterly results and SYNCOM FORMULATIONS share price and chart. For a sector overview, read our pharmaceuticals sector report.

SYNCOM FORMULATIONS Price History

Price Rs 8.4
Mkt Cap Rs m 6,612
Vol '000 2,810.5
P/E X 22.7
P/CF X 36.1
EPS (TTM) Rs 0.4
% ch % -2.1
No. of shares m 789.95
% ch week % -8.1
% ch 1-mth % -0.6
% ch 12-mth % 447.1
52 week H/L Rs 9.6/1.4
(As on Jul 23, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SYNCOM FORMULATIONS Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
SYNCOM FORMULATIONS EQUITY SHARE DATA
High Rs103321 
Low Rs2211NA 
Sales per share (Unadj.) Rs2.32.42.02.42.6 
Earnings per share (Unadj.) Rs0.10.10.10.10.2 
Diluted earnings per shareRs0.10.10.10.10.2 
Cash flow per share (Unadj.) Rs0.20.20.20.20.2 
Dividends per share (Unadj.) Rs0.020.02000 
Adj. dividends per shareRs0.020.020.000.000.00 
Dividend yield (eoy) %0.30.8000 
Book value per share (Unadj.) Rs1.41.51.61.71.9 
Adj. book value per shareRs1.41.51.51.71.8 
Shares outstanding (eoy) m780.65780.65780.65780.65780.65 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x2.61.10.90.50.3 
Avg P/E ratio x45.719.715.77.94.4 
P/CF ratio (eoy) x35.415.210.95.83.4 
Price / Book Value ratio x4.41.81.10.70.4 
Dividend payout %15.114.8000 
Avg Mkt Cap Rs m4,7312,0771,354874625 
No. of employees `000NANANANANA 
Total wages/salary Rs m135145148152158 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
SYNCOM FORMULATIONS INCOME DATA
Net Sales Rs m1,8221,8481,5851,8682,055 
Other income Rs m2728445152 
Total revenues Rs m1,8491,8761,6301,9192,107 
Gross profit Rs m166165116118167 
Depreciation Rs m3031374041 
Interest Rs m13325 
Profit before tax Rs m161159120127173 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m5753341630 
Profit after tax Rs m10410586111143 
Gross profit margin %9.19.07.36.38.1 
Effective tax rate %35.733.728.012.517.6 
Net profit margin %5.75.75.55.96.9 
SYNCOM FORMULATIONS BALANCE SHEET DATA
Current assets Rs m917865814813899 
Current liabilities Rs m657588427358312 
Net working cap to sales %14.315.024.424.428.6 
Current ratio x1.41.51.92.32.9 
Inventory Days Days7783799185 
Debtors Days Days9291878177 
Net fixed assets Rs m890974926947940 
Share capital Rs m781781781781781 
"Free" reserves Rs m306393439546676 
Net worth Rs m1,0871,1741,2191,3261,457 
Long term debt Rs m00000 
Total assets Rs m1,8071,8391,7401,7601,839 
Interest coverage x119.448.541.552.533.9 
Debt to equity ratio x00000 
Sales to assets ratio x1.01.00.91.11.1 
Return on assets %5.85.95.16.48.0 
Return on equity %9.59.07.18.49.8 
Return on capital %14.913.810.19.712.2 
Exports to sales %57.473.877.860.459.8 
Imports to sales %0.100.30.10.6 
Exports (fob) Rs m1,0451,3641,2341,1271,229 
Imports (cif) Rs m205212 
Fx inflow Rs m1,0451,3641,2341,1271,229 
Fx outflow Rs m688314 
Net fx Rs m1,0391,3561,2261,1241,215 
SYNCOM FORMULATIONS CASH FLOW
From Operations Rs m 241 138 -16 43 -5 
From Investments Rs m -227 -177 -22 24 14 
From Financial Activity Rs m -24 47 -20 -2 0 
Net Cashflow Rs m -11 8 -58 66 9 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Indian Promoters 41.2%
Foreign collaborators 0.0%
Indian inst/Mut Fund 0.0%
FIIs 0.0%
ADR/GDR 0.0%
Free float 58.8%
Shareholders 93,207
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 7 Niraj Industrial Estate, Off Mahakali Caves Road, Andheri (E), Mumbai - 400093
E-MAIL finance@sfil.in WEB www.sfil.in
TEL 022 2687 7700 / 11 FAX
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT Ankit Consultancy Pvt Ltd, Plot No 60, Electronic Complex, Pardeshipura
YEAR OF INC: 1988 BSE CODE: 524470 FV (Rs): 1 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   UNJHA FORMUL  SOURCE NATURAL FOODS  NARAYANA HRUDAYALAYA  ADVIK LABORS  SMS PHARMA  

Compare SYNCOM FORMULATIONS With:   UNJHA FORMUL  SOURCE NATURAL FOODS  NARAYANA HRUDAYALAYA  ADVIK LABORS  SMS PHARMA  




Today's Market

Sensex Ends 139 Points Higher; ICICI Bank, Wipro and ITC Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Views on news

Why Did Pharma Stocks Surge? (Views On News)

Jul 17, 2021

A look into the factors contributing to the rally in pharma stocks.

Bajaj Healthcare Rallies 11% on DRDO Nod to Manufacture Oral Covid Drug (Views On News)

Jul 8, 2021

Bajaj Healthcare has more than doubled investors' wealth in the year 2021 so far. The counter has delivered over 240% return in the last one year.

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

KIMS Shares Make Strong Debut Listing at a 22% Premium (Views On News)

Jun 28, 2021

KIMS shares pare gains after making a strong debut on the exchanges.

What Led to the Recent Surge in Shares of Thyrocare Technologies? (Views On News)

Jun 26, 2021

Shares of Thyrocare Technologies rallied over 7% and touched an all time high of Rs 1,465 on the BSE yesterday.

More Views on News

Most Popular

A 25 Bagger Indian Stock at the Centre of the Global Semiconductor Chip Shortage (Profit Hunter)

Jul 13, 2021

One technology company in India is grossly underrated despite its dominant role in semiconductor chip designing.

RBI Opens a New Market for Investors (Fast Profits Daily)

Jul 16, 2021

You now have a new way to create wealth. Grab it with both hands.

OPEC is Dying! RIP OPEC (Fast Profits Daily)

Jul 13, 2021

Why the global oil cartel is unravelling and how India stands to gain.

A Better Way than the Zomato IPO to Play the Food Delivery Megatrend (Profit Hunter)

Jul 14, 2021

A unique backdoor way of making big profits from smallcap companies.

Top 3 Risks for the Nifty Today (Fast Profits Daily)

Jul 12, 2021

Don't ignore the risks to the Nifty that are hiding in plain sight.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SYNCOM FORMULATIONS

  • Track your investment in SYNCOM FORMULATIONS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SYNCOM FORMULATIONS

SYNCOM FORMULATIONS 8-QTR ANALYSIS

COMPARE SYNCOM FORMULATIONS WITH

MARKET STATS